Literature DB >> 16505008

Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression.

Wieke Zuidervaart1, Paul J Hensbergen, Man-Chi Wong, Andre M Deelder, Cornelis P Tensen, Martine J Jager, Nelleke A Gruis.   

Abstract

PURPOSE: Patient survival in uveal melanoma may benefit from earlier recognition of potential metastases to the liver, but as yet, proper markers indicating metastases are not available. Identification of metastasis markers would therefore be of great value. The proteins that are expressed in two cell lines originating from two liver metastases were compared with the proteins expressed in a cell line obtained from the primary uveal melanoma of the same patient, to identify proteins that play a role in tumor progression as well as proteins that are expressed specifically in metastases.
METHODS: Protein analysis was performed by using two-dimensional gel electrophoresis. A subset of proteins was subsequently identified with mass spectrometry.
RESULTS: A set of 24 proteins was differentially expressed in both of the two metastatic cell lines compared with the cell line derived from the primary tumor. These proteins were subdivided into groups according to cellular function, with important roles in tumor development.
CONCLUSIONS: Tumor progression and development of metastases is a multicomplex system. Comparing protein expression in two cell lines derived from metastases with a cell line derived from a primary uveal melanoma from the same patient identified proteins involved in tumor progression, and proteins specifically expressed in the metastases, which have the potential of becoming clinically useful biomarkers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16505008     DOI: 10.1167/iovs.05-0314

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  Proteomic analyses of the Xiphophorus Gordon-Kosswig melanoma model.

Authors:  Amy N Perez; Lee Oehlers; Shelia J Heater; Rachell E Booth; Ronald B Walter; Wendi M David
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2011-06-06       Impact factor: 3.228

2.  Characterization of extracellular vesicles isolated from different liquid biopsies of uveal melanoma patients.

Authors:  Carmen Luz Pessuti; Deise Fialho Costa; Kleber S Ribeiro; Mohamed Abdouh; Thupten Tsering; Heloisa Nascimento; Alessandra G Commodaro; Allexya Affonso Antunes Marcos; Ana Claudia Torrecilhas; Rubens N Belfort; Rubens Belfort; Julia Valdemarin Burnier
Journal:  J Circ Biomark       Date:  2022-06-27

Review 3.  The protective role of HSP27 in ocular diseases.

Authors:  K Sooraj; Swati Shukla; Ranjeet Kaur; Jeewan Singh Titiyal; Jasbir Kaur
Journal:  Mol Biol Rep       Date:  2022-02-25       Impact factor: 2.742

4.  Ocular proteomics with emphasis on two-dimensional gel electrophoresis and mass spectrometry.

Authors:  Bent Honoré; Henrik Vorum; Nakul Mandal; Steffen Heegaard; Jan Ulrik Prause
Journal:  Biol Proced Online       Date:  2009-12-24       Impact factor: 3.244

Review 5.  Blood biomarkers for uveal melanoma.

Authors:  Pierre L Triozzi; Arun D Singh
Journal:  Future Oncol       Date:  2012-02       Impact factor: 3.674

6.  Characterization of three cell lines derived from fine needle biopsy of choroidal melanoma with metastatic outcome.

Authors:  Barry L Burgess; Nagesh P Rao; Ascia Eskin; Stanley F Nelson; Tara A McCannel
Journal:  Mol Vis       Date:  2011-02-25       Impact factor: 2.367

7.  A novel function for vimentin: the potential biomarker for predicting melanoma hematogenous metastasis.

Authors:  Man Li; Baogang Zhang; Baocun Sun; Xuan Wang; Xinchao Ban; Tao Sun; Zhiyong Liu; Xiulan Zhao
Journal:  J Exp Clin Cancer Res       Date:  2010-08-11

8.  Heat shock proteins in the human eye.

Authors:  Lærke Urbak; Henrik Vorum
Journal:  Int J Proteomics       Date:  2011-03-02

Review 9.  Proteomics of uveal melanoma: a minireview.

Authors:  Søren K O Abildgaard; Henrik Vorum
Journal:  J Oncol       Date:  2013-09-03       Impact factor: 4.375

10.  iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors.

Authors:  John W Crabb; Bo Hu; John S Crabb; Pierre Triozzi; Yogen Saunthararajah; Raymond Tubbs; Arun D Singh
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.